quipazine has been researched along with ergoline in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (57.14) | 18.7374 |
| 1990's | 10 (35.71) | 18.2507 |
| 2000's | 2 (7.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anlezark, GM; Horton, RW; Meldrum, BS | 1 |
| Carminati, R; Cocchi, D; Locatelli, V; Müller, EE | 1 |
| Jacobs, M; McRee, C; Meyer, DC | 1 |
| Breeding, M; Sanders-Bush, E | 1 |
| Czyrak, A; Maj, J; Mogilnicka, E | 1 |
| Alper, RH | 1 |
| Appel, JB; Callahan, PM | 1 |
| Fuller, CA; Miller, JD | 1 |
| Appel, JB; Cunningham, KA; West, KB | 1 |
| Amedro, J; Brown, L; Smith, D; Williams, G | 1 |
| Alper, RH; Snider, JM | 1 |
| Cohen, ML; Fuller, RW; Kurz, KD; Mason, NR; Meyers, DB; Parli, CJ; Smallwood, JK; Toomey, RE | 1 |
| Booth, NH; Hatch, RC; Jernigan, AD; Lipham, LB; Robbins, JD | 1 |
| Feuerstein, TJ; Hertting, G; Lupp, A; Neufang, B | 1 |
| Cohen, ML; Fuller, RW; Garbrecht, WL; Kurz, KD; Marzoni, GP; Mason, NR | 1 |
| Appel, JB; Callahan, PM; Cunningham, KA | 1 |
| Commissaris, RL; Mokler, DJ; Rech, RH; Warner, MR | 1 |
| Beninger, RJ | 1 |
| Commissaris, RL; Rech, RH | 2 |
| Broekkamp, CL; Garrigou, D; LLoyd, KG | 1 |
| Appel, JB; White, FJ | 1 |
| Calligaro, DO; Cohen, ML; Fuller, RW; Kurz, KD | 1 |
| Ahlborn, EN; Bailey, SP; Davis, JM | 2 |
| Carey, JE; Chen, C; Elliott, JM; Flanigan, TP; Kumar, C; McDonald, B; Newberry, NR; Newton, RA; Phipps, SL | 1 |
| Ebersole, BJ; Rosendorff, A; Sealfon, SC | 1 |
| Berg, KA; Clarke, WP; Cropper, JD; Emeson, RB; Niswender, CM; Sanders-Bush, E | 1 |
28 other study(ies) available for quipazine and ergoline
| Article | Year |
|---|---|
Dopamine agonists and audiogenic seizures: the relationship between protection against seizures and changes in monoamine metabolism.
Topics: Acoustic Stimulation; Animals; Apomorphine; Biogenic Amines; Brain; Bromocriptine; Dopamine; Ergolines; Ergonovine; Female; Lysergic Acid Diethylamide; Male; Mice; Mice, Inbred DBA; Quipazine; Seizures | 1978 |
Mechanisms underlying the prolactin-lowering effect of meterogoline in the rat.
Topics: Animals; Bromocriptine; Ergolines; Female; Male; Metergoline; Pituitary Gland, Anterior; Prolactin; Quipazine; Radioimmunoassay; Rats; Reserpine; Time Factors | 1978 |
Role of 5-hydroxytryptamine receptors on luteinizing-hormone-releasing hormone release in the ovariectomized, estradiol-treated rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Ergolines; Estradiol; Female; Gonadotropin-Releasing Hormone; Hypothalamus, Middle; Ketanserin; Ovariectomy; Pindolol; Preoptic Area; Quipazine; Radioimmunoassay; Rats; Receptors, Serotonin; Serotonin Antagonists; Suprachiasmatic Nucleus; Tetrahydronaphthalenes | 1992 |
Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Antiparkinson Agents; Cells, Cultured; Choroid Plexus; DOM 2,5-Dimethoxy-4-Methylamphetamine; Epithelial Cells; Ergolines; Hallucinogens; Male; Phosphatidylinositols; Quipazine; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Stereoisomerism | 1991 |
Some central pharmacological effects of the calcium channel antagonist flunarizine.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Body Temperature Regulation; Dopamine; Dopamine Antagonists; Drug Interactions; Ergolines; Fenfluramine; Flunarizine; Hypothermia; Male; Mice; Motor Activity; Quinpirole; Quipazine; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Species Specificity; Stereotyped Behavior; Yawning | 1991 |
Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat.
Topics: Amidines; Amphetamines; Animals; Corticosterone; Dexamethasone; Ergolines; Male; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists | 1990 |
Differentiation between the stimulus effects of (+)-lysergic acid diethylamide and lisuride using a three-choice, drug discrimination procedure.
Topics: Animals; Apomorphine; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Drug Interactions; Ergolines; Lisuride; Lysergic Acid Diethylamide; Male; Pentylenetetrazole; Quipazine; Rats; Rats, Inbred Strains; Serotonin Antagonists | 1990 |
The response of suprachiasmatic neurons of the rat hypothalamus to photic and serotonergic stimulation.
Topics: Action Potentials; Animals; Ergolines; Male; Metergoline; Photic Stimulation; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Suprachiasmatic Nucleus; Visual Pathways | 1990 |
Monoaminergic involvement in the behavioral effects of ergot derivatives.
Topics: Animals; Apomorphine; Conditioning, Psychological; Discrimination, Psychological; Dose-Response Relationship, Drug; Ergolines; Ergonovine; Ergot Alkaloids; Lisuride; Lysergic Acid Diethylamide; Male; Quipazine; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1985 |
A pharmacological analysis of the rat spinal cord serotonin (5-HT) autoreceptor.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Ergolines; Male; Piperazines; Potassium; Quipazine; Rats; Receptors, Serotonin; Serotonin; Spinal Cord; Spiperone; Tetrahydronaphthalenes; Tritium | 1988 |
Activation of serotonin2 (5-HT2) receptors by quipazine increases arterial pressure and renin secretion in conscious rats.
Topics: Animals; Blood Pressure; Ergolines; Heart Rate; Male; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Renin | 1987 |
Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
Topics: Animals; Brain; Corticosterone; Dose-Response Relationship, Drug; Ergolines; Guinea Pigs; Heart; Lysergic Acid; Male; Membranes; Muscle, Smooth, Vascular; Pergolide; Quipazine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Serotonin Antagonists; Trachea | 1988 |
Effect of clonidine, quipazine, and LY 53857 on the prolactin-suppressant action of bromocriptine in rats.
Topics: Animals; Bromocriptine; Clonidine; Drug Interactions; Ergolines; Male; Pituitary Gland, Anterior; Prolactin; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Serotonin Antagonists | 1986 |
False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine.
Topics: Animals; Caudate Nucleus; Domperidone; Ergolines; Female; Hippocampus; In Vitro Techniques; Male; Nomifensine; Quinpirole; Quipazine; Rabbits; Receptors, Dopamine; Serotonin; Serotonin Antagonists | 1986 |
Pharmacological activity of the isomers of LY53857, potent and selective 5-HT2 receptor antagonists.
Topics: Animals; Blood Pressure; Cerebral Cortex; Corticosterone; Decerebrate State; Ergolines; Isomerism; Male; Mathematics; Quipazine; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Receptors, Serotonin; Spiperone; Time Factors | 1985 |
Discriminative stimulus properties of lergotrile.
Topics: Animals; Apomorphine; Discrimination Learning; Dose-Response Relationship, Drug; Ergolines; Ergonovine; Haloperidol; Lisuride; Lysergic Acid Diethylamide; Male; Piperidines; Pizotyline; Quipazine; Rats; Rats, Inbred Strains; Sulpiride | 1984 |
Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
Topics: Amphetamines; Animals; Behavior, Animal; Cinanserin; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dose-Response Relationship, Drug; Ergolines; Lisuride; Lysergic Acid Diethylamide; Male; Metergoline; Pizotyline; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Reinforcement, Psychology; Serotonin; Serotonin Antagonists | 1983 |
Effects of metergoline and quipazine on locomotor activity of rats in novel and familiar environments.
Topics: Animals; Corpus Striatum; Environment, Controlled; Ergolines; Male; Metergoline; Motor Activity; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Serotonin | 1984 |
Interactions of metergoline with diazepam, quipazine, and hallucinogenic drugs on a conflict behavior in the rat.
Topics: Animals; Behavior, Animal; Conflict, Psychological; Diazepam; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drug Interactions; Ergolines; Hallucinogens; Lysergic Acid Diethylamide; Male; Metergoline; Psychotropic Drugs; Quipazine; Rats; Rats, Inbred Strains | 1982 |
Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomised rats.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Clonidine; Ergolines; Fenfluramine; Fluoxetine; Imipramine; Male; Metergoline; Mianserin; Olfactory Bulb; Quipazine; Rats; Serotonin; Serotonin Antagonists | 1980 |
Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions.
Topics: Animals; Apomorphine; Behavior, Animal; Biological Assay; Ergolines; Lisuride; Lysergic Acid Diethylamide; Male; Quipazine; Rats; Serotonin | 1982 |
Antagonism of the behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) and quipazine by metergoline.
Topics: Amphetamines; Animals; Behavior, Animal; Conditioning, Operant; DOM 2,5-Dimethoxy-4-Methylamphetamine; Ergolines; Male; Metergoline; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Reinforcement Schedule | 1981 |
Comparative 5-HT2-receptor antagonist activity of amesergide and its active metabolite 4-hydroxyamesergide in rats and rabbits.
Topics: Adenosine Diphosphate; Animals; Blood Pressure; Corticosterone; Ergolines; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Platelet Aggregation; Quipazine; Rabbits; Radioligand Assay; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Cell Surface; Serotonin Antagonists | 1994 |
Neuroendocrine and substrate responses to altered brain 5-HT activity during prolonged exercise to fatigue.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Blood Glucose; Brain; Dopamine; Ergolines; Fatigue; Fatty Acids, Nonesterified; Glycogen; Male; Physical Exertion; Quipazine; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists | 1993 |
Serotonergic agonists and antagonists affect endurance performance in the rat.
Topics: Amidines; Animals; Dose-Response Relationship, Drug; Ergolines; Female; Injections, Intraperitoneal; Male; Physical Endurance; Placebos; Quipazine; Rats; Rats, Wistar; Running; Serotonin Antagonists; Time Factors | 1993 |
Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
Topics: Adrenergic alpha-Agonists; Amphetamines; Antiparkinson Agents; Calcium; Choroid Plexus; Electrophysiology; Ergolines; Ergotamine; Frontal Lobe; Hallucinogens; Humans; Hydrolysis; Ketanserin; Lysergic Acid Diethylamide; Mescaline; Methoxydimethyltryptamines; Neuroblastoma; Phosphatidylinositols; Piperazines; Quipazine; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Recombinant Proteins; RNA, Messenger; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium; Tumor Cells, Cultured | 1996 |
Conserved helix 7 tyrosine functions as an activation relay in the serotonin 5HT(2C) receptor.
Topics: Amino Acid Motifs; Amphetamines; Binding, Competitive; Cell Line; Conserved Sequence; Ergolines; Humans; Indoles; Inositol Phosphates; Ligands; Mianserin; Mutation; Protein Structure, Secondary; Pyridines; Quipazine; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection; Tyrosine | 2000 |
RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity.
Topics: Amphetamines; Animals; Arachidonic Acid; Binding, Competitive; Bufotenin; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Ergolines; Inositol Phosphates; Lysergic Acid Diethylamide; Piperazines; Protein Isoforms; Quipazine; Radioligand Assay; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; RNA Editing; Serotonin; Serotonin Receptor Agonists; Tritium | 2001 |